Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorTajes, M.
dc.contributor.authorDíez‑López, C.
dc.contributor.authorEnjuanes, Cristina
dc.contributor.authorMoliner, Pedro
dc.contributor.authorFerreiro, José Luis
dc.contributor.authorGaray, A.
dc.contributor.authorYañez Bisbe, Laia
dc.contributor.authorBenito Villabriga, Begoña
dc.date.accessioned2022-01-12T17:41:16Z
dc.date.available2022-01-12T17:41:16Z
dc.date.issued2021-05-17
dc.identifier.citationTajes M, Díez-López C, Enjuanes C, Moliner P, Ferreiro JL, Garay A, et al. Neurohormonal activation induces intracellular iron deficiency and mitochondrial dysfunction in cardiac cells. Cell Biosci. 2021 May 17;11:89.
dc.identifier.issn2045-3701
dc.identifier.urihttps://hdl.handle.net/11351/6770
dc.descriptionCardiac cell; Iron deficiency; Neurohormonal activation
dc.description.abstractBackground Iron deficiency (ID) is common in patients with heart failure (HF) and is associated with poor outcomes, yet its role in the pathophysiology of HF is not well-defined. We sought to determine the consequences of HF neurohormonal activation in iron homeostasis and mitochondrial function in cardiac cells. Methods HF was induced in C57BL/6 mice by using isoproterenol osmotic pumps and embryonic rat heart-derived H9c2 cells were subsequently challenged with Angiotensin II and/or Norepinephrine. The expression of several genes and proteins related to intracellular iron metabolism were assessed by Real time-PCR and immunoblotting, respectively. The intracellular iron levels were also determined. Mitochondrial function was analyzed by studying the mitochondrial membrane potential, the accumulation of radical oxygen species (ROS) and the adenosine triphosphate (ATP) production. Results Hearts from isoproterenol-stimulated mice showed a decreased in both mRNA and protein levels of iron regulatory proteins, transferrin receptor 1, ferroportin 1 and hepcidin compared to control mice. Furthermore, mitoferrin 2 and mitochondrial ferritin were also downregulated in the hearts from HF mice. Similar data regarding these key iron regulatory molecules were found in the H9c2 cells challenged with neurohormonal stimuli. Accordingly, a depletion of intracellular iron levels was found in the stimulated cells compared to non-stimulated cells, as well as in the hearts from the isoproterenol-induced HF mice. Finally, neurohormonal activation impaired mitochondrial function as indicated by the accumulation of ROS, the impaired mitochondrial membrane potential and the decrease in the ATP levels in the cardiac cells. Conclusions HF characteristic neurohormonal activation induced changes in the regulation of key molecules involved in iron homeostasis, reduced intracellular iron levels and impaired mitochondrial function. The current results suggest that iron could be involved in the pathophysiology of HF.
dc.language.isoeng
dc.publisherBMC
dc.relation.ispartofseriesCell and Bioscience;11
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectAnèmia ferropènica
dc.subjectInsuficiència cardíaca
dc.subject.meshAnemia, Iron-Deficiency
dc.subject.meshHeart Failure
dc.subject.meshIron-Regulatory Proteins
dc.titleNeurohormonal activation induces intracellular iron deficiency and mitochondrial dysfunction in cardiac cells
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1186/s13578-021-00605-5
dc.subject.decsanemia ferropénica
dc.subject.decsinsuficiencia cardíaca
dc.subject.decsproteínas reguladoras del hierro
dc.relation.publishversionhttps://doi.org/10.1186/s13578-021-00605-5
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Tajes M, Ferreiro JL] Bio Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain. Cardiology Department, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain. [Díez-López C] Bio Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain. Cardiology Department, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain. Advanced Heart Failure and Heart Transplant Unit, Cardiology Department, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain. Department of Clinical Sciences, School of Medicine, University of Barcelona, Barcelona, Spain. [Enjuanes C, Moliner P, Garay A] Bio Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain. Cardiology Department, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain. Community Heart Failure Program, Cardiology Department, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain. [Yañez-Bisbe L] Programa de Biologia Vascular i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Benito B] Programa de Biologia Vascular i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.identifier.pmid34001233
dc.identifier.wos000657739600003
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record